title: Sequence-dependent structural dynamics of primate adenosine-to-inosine editing substrates.
abstract: Humans have the highest level of adenosine-to-inosine (A-to-I) editing amongst primates, yet the reasons for this difference remain unclear. Sequence analysis of the Alu Sg elements (A-to-I RNA substrates) corresponding to the Nup50 gene in human, chimp, and rhesus reveals subtle sequence variations surrounding the edit sites. We have developed three constructs that represent human (HuAp5), chimp (ChAp5), and rhesus (RhAp5) Nup50 Alu Sg A-to-I editing substrates. Here, 2-aminopurine (2-Ap) was substituted for edited adenosine (A5) so as to monitor the fluorescence intensity with respect to temperature. UV and steady-state fluorescence (SSF) T(M) plots indicate that local and global unfolding are coincident, with the human construct displaying a T(M) of approximately 70°C, compared to 60°C for chimp and 54°C for rhesus. However, time-resolved fluorescence (TRF) resolves three different fluorescence lifetimes that we assign to folded, intermediate(s), and unfolded states. The TRF data fit well to a two-intermediate model, whereby both intermediates (M, J) are in equilibrium with each other, and the folded/unfolded states. Our model suggests that, at 37°C, human state J and the folded state will be the most heavily populated in comparison to the other primate constructs. In order for adenosine deaminase acting on RNA (ADAR) to efficiently dock, a stable duplex must be present that corresponds to the human construct, globally. Next, the enzyme must "flip out" the base of interest to facilitate the A-to-I conversion; a nucleotide in an intermediate-like position would enhance this conformational change. Our experiments demonstrate that subtle variations in RNA sequence might contribute to the high A-to-I editing levels found in humans.
authors.affiliation: Department of Chemistry, Simon Fraser University, Burnaby, British Columbia, Canada. mdahabib@sfu.ca
authors.forename: Michael Samir
authors.initials: MS
authors.lastname: Dahabieh
authors.forename: Dhrubajyoti
authors.initials: D
authors.lastname: Samanta
authors.forename: Jean-Claude
authors.initials: JC
authors.lastname: Brodovitch
authors.forename: Christian
authors.initials: C
authors.lastname: Frech
authors.forename: Melanie A
authors.initials: MA
authors.lastname: O'Neill
authors.forename: B Mario
authors.initials: BM
authors.lastname: Pinto
mesh_terms: D015075:2-Aminopurine / Q000378:metabolism; D000241:Adenosine / Q000737:chemistry* / Q000378:metabolism; D000818:Animals; D001483:Base Sequence; D006801:Humans; D007288:Inosine / Q000737:chemistry* / Q000378:metabolism; D055029:Inverted Repeat Sequences; D008253:Macaca mulatta; D015335:Molecular Probes / Q000378:metabolism; D028861:Nuclear Pore Complex Proteins / Q000235:genetics; D009687:Nuclear Proteins / Q000235:genetics; D009691:Nucleic Acid Denaturation; D002679:Pan troglodytes; D017393:RNA Editing; D020871:RNA Stability; D013050:Spectrometry, Fluorescence; D044366:Transition Temperature
chemical_list: D015335:Molecular Probes; C121702:NUP50 protein, human; D028861:Nuclear Pore Complex Proteins; D009687:Nuclear Proteins; D015075:2-Aminopurine; D007288:Inosine; D000241:Adenosine